BMPR2 Mutation and Metabolic Reprogramming in Pulmonary Arterial Hypertension
暂无分享,去创建一个
[1] S. Duval,et al. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry , 2022, Journal of the American Heart Association.
[2] Luman Liu,et al. Platelet-Derived TGF (Transforming Growth Factor)-β1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation , 2022, Hypertension.
[3] Jin Lin,et al. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis , 2021, Arthritis Research & Therapy.
[4] M. Humbert,et al. Sex and gender in pulmonary arterial hypertension , 2021, European Respiratory Review.
[5] Traci L. Marin,et al. Roles of KLF4 and AMPK in the inhibition of glycolysis by pulsatile shear stress in endothelial cells , 2021, Proceedings of the National Academy of Sciences.
[6] Raja Chakraborty,et al. Targeting smooth muscle cell phenotypic switching in vascular disease , 2021, JVS-vascular science.
[7] Zulong Sheng,et al. PTBP1 Targets ILK to Regulate the Hypoxia-Induced Phenotypic Transformation of Pulmonary Artery Smooth Muscle Cells , 2021, Drug design, development and therapy.
[8] Michael J. Podolsky,et al. Autoregulation of insulin receptor signaling through MFGE8 and the αvβ5 integrin , 2021, Proceedings of the National Academy of Sciences.
[9] M. Snyder,et al. ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension , 2021, Circulation.
[10] D. Levine. Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients. , 2021, The American journal of managed care.
[11] S. Erzurum,et al. Metabolism in Pulmonary Hypertension. , 2021, Annual review of physiology.
[12] S. Wort,et al. S92 Hepcidin and interleukin-6 downregulate BMPR2 and dysregulate BMPR2 downstream pathways; implications for pulmonary artery hypertension , 2021 .
[13] M. Ghigna,et al. Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms , 2021, Cells.
[14] Alicia M. Salvi,et al. Fueling the cytoskeleton – links between cell metabolism and actin remodeling , 2021, Journal of Cell Science.
[15] Y. Urade,et al. PERK inhibition attenuates vascular remodeling in pulmonary arterial hypertension caused by BMPR2 mutation , 2021, Science Signaling.
[16] P. Knaus,et al. Differential Impact of Fluid Shear Stress and YAP/TAZ on BMP/TGF-β Induced Osteogenic Target Genes. , 2021, Advanced biology.
[17] N. Morrell,et al. Approaches to treat pulmonary arterial hypertension by targeting bmpr2 - from cell membrane to nucleus. , 2021, Cardiovascular research.
[18] T. He,et al. BMP4 augments the survival of hepatocellular carcinoma (HCC) cells under hypoxia and hypoglycemia conditions by promoting the glycolysis pathway. , 2021, American journal of cancer research.
[19] Li Linqing,et al. Hypoxia-induced PINK1/Parkin-mediated mitophagy promotes pulmonary vascular remodeling. , 2020, Biochemical and biophysical research communications.
[20] P. Moreira,et al. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation , 2020, Acta neuropathologica communications.
[21] C. Rhodes. The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg? , 2020, European Respiratory Journal.
[22] S. Ylä-Herttuala,et al. BMP6/TAZ-Hippo signaling modulates angiogenesis and endothelial cell response to VEGF , 2020, Angiogenesis.
[23] S. Archer,et al. Endothelial BMPR2 Loss Drives a Proliferative Response to BMP (Bone Morphogenetic Protein) 9 via Prolonged Canonical Signaling , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[24] Jianping Zhao,et al. Absence of the MFG‐E8 gene prevents hypoxia‐induced pulmonary hypertension in mice , 2020, Journal of cellular physiology.
[25] H. Yamaguchi,et al. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations , 2020, Frontiers in Oncology.
[26] C. Coman,et al. A multi-omics analysis reveals the unfolded protein response regulon and stress-induced resistance to folate-based antimetabolites , 2020, Nature Communications.
[27] Y. Mao,et al. Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension , 2020, European Respiratory Journal.
[28] K. Stenmark,et al. RNA-Binding Proteins in Pulmonary Hypertension , 2020, International journal of molecular sciences.
[29] K. Wagner,et al. Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A , 2020, Scientific Reports.
[30] D. Kamp,et al. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts , 2020, International journal of molecular sciences.
[31] M. Mayr,et al. Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration , 2020, Circulation.
[32] Li Huang,et al. Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation , 2020, Journal of Experimental & Clinical Cancer Research.
[33] Yanqin Cheng,et al. LncRNA-Ang362 Promotes Pulmonary Arterial Hypertension by Regulating miR-221 and miR-222. , 2020, Shock.
[34] G. Hansmann,et al. Activation of The Metabolic Master Regulator PPARγ - A Potential PIOneering Therapy for Pulmonary Arterial Hypertension. , 2020, American journal of respiratory cell and molecular biology.
[35] J. Newman,et al. BMPR2 dysfunction impairs insulin signaling and glucose homeostasis in cardiomyocytes. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[36] S. Li,et al. RAD51 is a potential marker for prognosis and regulates cell proliferation in pancreatic cancer , 2019, Cancer Cell International.
[37] K. Wagner,et al. Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression , 2019, Cells.
[38] P. Schumacker,et al. Roles of HIF1 and HIF2 in pulmonary hypertension: it all depends on the context , 2019, European Respiratory Journal.
[39] C. Ruppert,et al. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics , 2019, PLoS biology.
[40] F. Cheng,et al. Integrative proteomics and phosphoproteomics in pulmonary arterial hypertension , 2019, Scientific Reports.
[41] Jodie L Babitt,et al. Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice , 2019, Hepatology.
[42] H. Aburatani,et al. The ALK-1/SMAD/ATOH8 axis attenuates hypoxic responses and protects against the development of pulmonary arterial hypertension , 2019, Science Signaling.
[43] T. Hla,et al. Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.
[44] M. Humbert,et al. PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) , 2019, Pulmonary hypertension.
[45] Surinder Kumar,et al. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension , 2019, European Respiratory Journal.
[46] M. Zhang,et al. PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension , 2019, Proceedings of the National Academy of Sciences.
[47] B. Himes,et al. Genome-wide CRISPR screen identifies suppressors of endoplasmic reticulum stress-induced apoptosis , 2019, Proceedings of the National Academy of Sciences.
[48] H. Zeng,et al. Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease , 2018, Journal of cellular physiology.
[49] M. Snyder,et al. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1–Mediated Metabolic and Epigenetic Changes , 2019, Circulation research.
[50] Shaoliang Chen,et al. S-nitrosation impairs KLF4 activity and instigates endothelial dysfunction in pulmonary arterial hypertension , 2019, Redox biology.
[51] R. Derynck,et al. Enhanced TGF-β Signaling Contributes to the Insulin-Induced Angiogenic Responses of Endothelial Cells , 2019, iScience.
[52] Paul G. Williams,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension , 2019, European Respiratory Journal.
[53] Huilin Yang,et al. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma , 2018, EBioMedicine.
[54] Yan-ting Zhu,et al. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway , 2018, Cellular Physiology and Biochemistry.
[55] A. Hata,et al. Bone morphogenetic protein signaling is required for RAD51-mediated maintenance of genome integrity in vascular endothelial cells , 2018, Communications Biology.
[56] K. Mills,et al. Enhancing the efficacy of glycolytic blockade in cancer cells via RAD51 inhibition , 2018, Cancer biology & therapy.
[57] S. Chan,et al. Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains , 2018, The Journal of clinical investigation.
[58] S. Ylä-Herttuala,et al. Differential but Complementary HIF1α and HIF2α Transcriptional Regulation. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[59] S. Wort,et al. Pulmonary Arterial Hypertension: Iron Matters , 2018, Front. Physiol..
[60] A. Al Haj Zen,et al. MicroRNA-148b Targets the TGF-β Pathway to Regulate Angiogenesis and Endothelial-to-Mesenchymal Transition during Skin Wound Healing , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[61] Patty J. Lee,et al. Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both. , 2018, American journal of physiology. Lung cellular and molecular physiology.
[62] J. Voorhees,et al. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts , 2018, Cell Communication and Signaling.
[63] Henning Gall,et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension , 2018, Nature Communications.
[64] P. Ježek,et al. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis , 2017, Circulation.
[65] P. Carmeliet,et al. Identification of MicroRNA-124 as a Major Regulator of Enhanced Endothelial Cell Glycolysis in Pulmonary Arterial Hypertension via PTBP1 (Polypyrimidine Tract Binding Protein) and Pyruvate Kinase M2 , 2017, Circulation.
[66] S. Mundlos,et al. BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARγ and GLUT4 upregulation , 2017, Scientific Reports.
[67] T. Force,et al. Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. , 2017, Journal of molecular and cellular cardiology.
[68] J. Newman,et al. Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension , 2017, Pulmonary circulation.
[69] J. Fessel,et al. Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects , 2017, European Respiratory Journal.
[70] Pin-i Chen,et al. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-&bgr; in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[71] G. Hansmann,et al. PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism. , 2017, Cell metabolism.
[72] Nirav Shah,et al. Novel Crosstalk between Insulin and TGF‐beta signaling in Vascular Endothelial Cells , 2017 .
[73] J. Sheu,et al. Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling , 2017, Scientific Reports.
[74] S. Provencher,et al. The cancer theory of pulmonary arterial hypertension , 2017, Pulmonary circulation.
[75] Jamey D. Young,et al. Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension , 2017, Pulmonary circulation.
[76] G. Inman,et al. TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling , 2017, Nature Communications.
[77] W. Chung,et al. The role of genetics in pulmonary arterial hypertension , 2017, The Journal of pathology.
[78] J. Newman,et al. Mechanisms of Lipid Accumulation in the Bone Morphogenetic Protein Receptor Type 2 Mutant Right Ventricle. , 2016, American journal of respiratory and critical care medicine.
[79] J. Loscalzo,et al. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. , 2016, The Journal of clinical investigation.
[80] B. Jiang,et al. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis , 2016, Oncotarget.
[81] M. Goumans,et al. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle , 2016, Circulation.
[82] R. Gerszten,et al. Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial Hypertension , 2016, Circulation.
[83] Jianhua Wang,et al. The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis. , 2016, Carcinogenesis.
[84] M. Bennett,et al. Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.
[85] Stephen Kaptoge,et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis , 2016, The Lancet. Respiratory medicine.
[86] Shuibang Wang,et al. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. , 2016, American journal of physiology. Lung cellular and molecular physiology.
[87] Liangming Liu,et al. Role of miR-124 and miR-141 in the regulation of vascular reactivity and the relationship to RhoA and Rac1 after hemorrhage and hypoxia. , 2016, American journal of physiology. Heart and circulatory physiology.
[88] J. Cogan,et al. Estrogen Metabolite 16&agr;-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism , 2016, Circulation.
[89] A. Satyanarayana,et al. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[90] M. Mcgoon,et al. The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress , 2015, European Respiratory Journal.
[91] S. Keshavjee,et al. A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung , 2015, PloS one.
[92] A. Hemnes,et al. Fatty Acid Metabolism in Pulmonary Arterial Hypertension: Role in Right Ventricular Dysfunction and Hypertrophy , 2015, Pulmonary circulation.
[93] S. Gräf,et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension , 2015, Nature Medicine.
[94] M. Haigis,et al. Intersections between mitochondrial sirtuin signaling and tumor cell metabolism , 2015, Critical reviews in biochemistry and molecular biology.
[95] Pin-i Chen,et al. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension. , 2015, Cell metabolism.
[96] A. Kenworthy,et al. Heterozygous Null Bone Morphogenetic Protein Receptor Type 2 Mutations Promote SRC Kinase-dependent Caveolar Trafficking Defects and Endothelial Dysfunction in Pulmonary Arterial Hypertension* , 2014, The Journal of Biological Chemistry.
[97] S. Provencher,et al. Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans. , 2014, Cell metabolism.
[98] K. Bloch,et al. BMP type II receptors have redundant roles in the regulation of hepatic hepcidin gene expression and iron metabolism. , 2014, Blood.
[99] W. Wallace,et al. Systems-level regulation of microRNA networks by miR-130 / 301 promotes pulmonary hypertension , 2022 .
[100] M. Furuhashi,et al. Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension. , 2014, American journal of physiology. Heart and circulatory physiology.
[101] B. Grygiel-Górniak. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.
[102] M. Eghbali,et al. Influence of sex differences on microRNA gene regulation in disease , 2014, Biology of Sex Differences.
[103] L. Gleaves,et al. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension. , 2014, American journal of respiratory and critical care medicine.
[104] D. Wasserman,et al. Hyperoxia synergizes with mutant bone morphogenic protein receptor 2 to cause metabolic stress, oxidant injury, and pulmonary hypertension. , 2013, American journal of respiratory cell and molecular biology.
[105] P. Tsai,et al. Circulating microRNAs have a sex-specific association with metabolic syndrome , 2013, Journal of Biomedical Science.
[106] Y. Suárez,et al. MicroRNAs as pharmacological targets in endothelial cell function and dysfunction. , 2013, Pharmacological research.
[107] Lingying Ye,et al. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells. , 2013, American journal of physiology. Lung cellular and molecular physiology.
[108] Kishore R. Sakharkar,et al. Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology , 2013, Journal of drug targeting.
[109] S. Archer,et al. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension , 2013, Pulmonary circulation.
[110] W. Chung,et al. Genetics and genomics of pulmonary arterial hypertension. , 2013, Journal of the American College of Cardiology.
[111] J. Newman,et al. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[112] L. Gleaves,et al. A potential role for insulin resistance in experimental pulmonary hypertension , 2012, European Respiratory Journal.
[113] J. Cailhier,et al. MFG-E8 Released by Apoptotic Endothelial Cells Triggers Anti-Inflammatory Macrophage Reprogramming , 2012, PloS one.
[114] R. Hamid,et al. Pulmonary Circulation | April-june 2012 | Vol 2 | No 2 Research Ar Ticle Metabolomic Analysis of Bone Morphogenetic Protein Receptor Type 2 Mutations in Human Pulmonary Endothelium Reveals Widespread Metabolic Reprogramming Several Animal Models of Pah , 2022 .
[115] R. Trembath,et al. BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. , 2012, Human molecular genetics.
[116] G. Owens,et al. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.
[117] R. Tuder,et al. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. , 2012, American journal of respiratory and critical care medicine.
[118] D. R. Laybutt,et al. Inhibition of Id1 Augments Insulin Secretion and Protects Against High-Fat Diet–Induced Glucose Intolerance , 2011, Diabetes.
[119] Howard Y. Chang,et al. Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. , 2011, The Journal of clinical investigation.
[120] P. Reynolds,et al. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension , 2011, European Respiratory Journal.
[121] W. Seeger,et al. Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension , 2011, PloS one.
[122] J. Fessel,et al. Oxidative injury is a common consequence of BMPR2 mutations , 2011, Pulmonary Circulation.
[123] J. Fessel,et al. Oxidative injury is a common consequence of BMPR2 mutations. , 2010, Pulmonary circulation.
[124] S. Archer,et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle , 2011, Journal of Molecular Medicine.
[125] A. Hemnes,et al. Pulmonary hypertension in women , 2010, Expert review of cardiovascular therapy.
[126] R. Trembath,et al. Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension , 2010, Circulation.
[127] Jia Yu,et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. , 2010, Cancer research.
[128] E. K. Weir,et al. Basic Science of Pulmonary Arterial Hypertension for Clinicians: New Concepts and Experimental Therapies , 2010, Circulation.
[129] J. Mitchell,et al. The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension , 2010, PloS one.
[130] Dianqing Wu,et al. GSK3: a multifaceted kinase in Wnt signaling. , 2010, Trends in biochemical sciences.
[131] B. Krishnamachary,et al. Cardiovascular , Pulmonary and Renal Pathology Hypoxia Inducible-Factor 1 Regulates the Metabolic Shift of Pulmonary Hypertensive Endothelial Cells , 2010 .
[132] R. Speich,et al. Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 Pathway , 2009, Circulation research.
[133] R. Trembath,et al. Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells* , 2009, The Journal of Biological Chemistry.
[134] N. Morrell,et al. Altered Bone Morphogenetic Protein and Transforming Growth Factor-β Signaling in Rat Models of Pulmonary Hypertension: Potential for Activin Receptor-Like Kinase-5 Inhibition in Prevention and Progression of Disease , 2009, Circulation.
[135] J. Axelrod,et al. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathways , 2009, The Journal of cell biology.
[136] N. Rudarakanchana,et al. Failure of bone morphogenetic protein receptor trafficking in pulmonary arterial hypertension: potential for rescue. , 2008, Human molecular genetics.
[137] Jean Mosser,et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. , 2008, Blood.
[138] R. S. Johnson,et al. Biology of HIF-1α , 2008, Cell Death and Differentiation.
[139] R. Trembath,et al. Regulation of bone morphogenetic protein signalling in human pulmonary vascular development , 2008, The Journal of pathology.
[140] J. Dyck,et al. Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.
[141] A. Paterson,et al. Genetic anticipation and breast cancer: a prospective follow‐up study , 1999, Breast Cancer Research and Treatment.
[142] P. Carmeliet,et al. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. , 2003, The Journal of clinical investigation.
[143] G. Semenza,et al. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis , 2001, The Journal of pathology.
[144] T. Bayless,et al. Methodologic Pitfalls in the Determination of Genetic Anticipation: The Case of Crohn Disease , 2001, Annals of Internal Medicine.
[145] M. Humbert,et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.
[146] S. Folstein,et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. , 1995, American journal of human genetics.
[147] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.